EFNB2 is expressed abnormally high in multiple cancers, such as gastric cancer (Kataoka et al., 2002; Tachibana et al., 2007; Yavrouian et al., 2008; Li et al., 2015; Li et al., 2017). Here, EFNB2 is linked to gastric cancer.